Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3) 3
life sciences & biomedicine (3) 3
science & technology (3) 3
age (2) 2
aged (2) 2
biomarkers, tumor - metabolism (2) 2
cancer (2) 2
male (2) 2
middle aged (2) 2
urology (2) 2
adalimumab (1) 1
adalumimab (1) 1
adult (1) 1
aged, 80 and over (1) 1
analysis (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antigens, neoplasm - metabolism (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antirheumatic agents - adverse effects (1) 1
arthritis (1) 1
arthritis, rheumatoid - drug therapy (1) 1
autoimmune diseases (1) 1
biological and medical sciences (1) 1
biopsy (1) 1
bladder (1) 1
carcinoma (1) 1
carcinoma in situ - metabolism (1) 1
carcinoma in situ - pathology (1) 1
carcinoma, papillary - metabolism (1) 1
carcinoma, papillary - pathology (1) 1
care and treatment (1) 1
chromatography, liquid (1) 1
classification (1) 1
clinical trials (1) 1
combined modality therapy (1) 1
coumarins - chemistry (1) 1
cysts (1) 1
deoxyguanosine - analogs & derivatives (1) 1
deoxyguanosine - chemistry (1) 1
dna topoisomerases, type ii - metabolism (1) 1
dna-binding proteins - metabolism (1) 1
double prime b-cell lymphoma (1) 1
double-blind method (1) 1
dysplasia (1) 1
etanarcept (1) 1
etanercept (1) 1
female (1) 1
histology (1) 1
immunoglobulin g - adverse effects (1) 1
immunohistochemistry (1) 1
immunoproliferative diseases (1) 1
immunosuppressive agents (1) 1
infliximab (1) 1
ki-67 antigen - metabolism (1) 1
lymphoid tissue (1) 1
lymphoma (1) 1
lymphoma - epidemiology (1) 1
mass spectrometry (1) 1
medical research (1) 1
medical sciences (1) 1
medicine & public health (1) 1
medicine, experimental (1) 1
minichromosome maintenance complex component 2 - metabolism (1) 1
miscellaneous (1) 1
monoclonal antibodies (1) 1
necrosis (1) 1
neoadjuvant therapy - methods (1) 1
nephrology. urinary tract diseases (1) 1
nf-kappa b - metabolism (1) 1
oncology (1) 1
oxidative stress (1) 1
pathology (1) 1
plant extracts - administration & dosage (1) 1
predictive value of tests (1) 1
pregnancy (1) 1
prevention and actions (1) 1
proex c (1) 1
prostate-specific antigen - metabolism (1) 1
prostatectomy (1) 1
prostatic neoplasms - drug therapy (1) 1
prostatic neoplasms - surgery (1) 1
public health. hygiene (1) 1
public health. hygiene-occupational medicine (1) 1
punicaceae - chemistry (1) 1
randomized controlled trials as topic (1) 1
reactive (1) 1
reagent kits, diagnostic (1) 1
receptors, tumor necrosis factor (1) 1
reviews (1) 1
rheumatoid arthritis (1) 1
rheumatoid factor (1) 1
rheumatology (1) 1
ribosomal protein s6 kinases - metabolism (1) 1
sensitivity and specificity (1) 1
statistics (1) 1
tumor necrosis factor (1) 1
tumor necrosis factor- alpha (1) 1
tumor necrosis factor-alpha - antagonists & inhibitors (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies
by Wong, Anna K and Wong, Anna K and Kerkoutian, Susan and Kerkoutian, Susan and Said, Jonathan and Said, Jonathan and Rashidi, Hooman and Rashidi, Hooman and Pullarkat, Sheeja T and Pullarkat, Sheeja T
Clinical rheumatology, ISSN 0770-3198, 4/2012, Volume 31, Issue 4, pp. 631 - 636
Medicine & Public Health | Infliximab | Tumor necrosis factor | Rheumatoid arthritis | Rheumatology | Adalumimab | Etanarcept | Lymphoma | Life Sciences & Biomedicine | Science & Technology | Lymphoma - epidemiology | Antibodies, Monoclonal, Humanized - adverse effects | Humans | Antibodies, Monoclonal - adverse effects | Immunoglobulin G - adverse effects | Randomized Controlled Trials as Topic | Etanercept | Receptors, Tumor Necrosis Factor | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - adverse effects | Adalimumab | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Rheumatoid factor | Medical research | Care and treatment | Medicine, Experimental | Arthritis | Immunosuppressive agents | Tumors | Cancer | Necrosis | double prime B-cell lymphoma | etanercept | infliximab | Immunoproliferative diseases | Clinical trials | Lymphoid tissue | Statistics | Reviews | Classification | Monoclonal antibodies | Autoimmune diseases | Age | Tumor necrosis factor- alpha | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions
by Moatamed, Neda A., MD and Vergara-Lluri, Maria E., MD and Lu, David, MD and Apple, Sophia K., MD and Kerkoutian, Susan, MD and Rao, Jian-Yu, MD
Human pathology, ISSN 0046-8177, 2013, Volume 44, Issue 11, pp. 2509 - 2517
Pathology | Histology | Carcinoma | ProEx C | Reactive | Urothelium | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Predictive Value of Tests | Urothelium - metabolism | Humans | Middle Aged | Ureteral Neoplasms - pathology | Male | Urinary Bladder - pathology | Carcinoma, Papillary - metabolism | Urothelium - pathology | DNA-Binding Proteins - metabolism | Young Adult | Sensitivity and Specificity | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Antigens, Neoplasm - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Urinary Bladder Neoplasms - metabolism | DNA Topoisomerases, Type II - metabolism | Urinary Bladder - metabolism | Carcinoma in Situ - pathology | Minichromosome Maintenance Complex Component 2 - metabolism | Carcinoma, Papillary - pathology | Pregnancy | Biopsy | Reagent Kits, Diagnostic | Aged | Carcinoma in Situ - metabolism | Antimitotic agents | Dysplasia | Antineoplastic agents | Analysis | Bladder | Cysts | Age | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text MP53-01 PERFORMANCE OF MULTI-PARAMETRIC MRI FOR HIGH GRADE PROSTATE CANCER: CORRELATION WITH WHOLE-MOUNT PATHOLOGY
by Le, Jesse and Tan, Nelly and Kerkoutian, Susan and Margolis, Daniel and Lu, David and Kwan, Lorna and Raman, Steven and Reiter, Robert
The Journal of urology, ISSN 0022-5347, 04/2014, Volume 191, Issue 4, pp. e588 - e588
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy
by Freedland, Stephen J and Carducci, Michael and Kroeger, Nils and Partin, Alan and Rao, Jian-Yu and Jin, Yusheng and Kerkoutian, Susan and Wu, Hong and Li, Yunfeng and Creel, Patricia and Mundy, Kelly and Gurganus, Robin and Fedor, Helen and King, Serina A and Zhang, Yanjun and Heber, David and Pantuck, Allan J
Cancer prevention research (Philadelphia, Pa.), ISSN 1940-6207, 10/2013, Volume 6, Issue 10, pp. 1120 - 1127
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Public health. Hygiene-occupational medicine | Public health. Hygiene | Miscellaneous | Prevention and actions | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Punicaceae - chemistry | Double-Blind Method | Oxidative Stress | Prostatic Neoplasms - surgery | Ribosomal Protein S6 Kinases - metabolism | Humans | Middle Aged | Coumarins - chemistry | Ki-67 Antigen - metabolism | Male | NF-kappa B - metabolism | Combined Modality Therapy | Deoxyguanosine - chemistry | Plant Extracts - administration & dosage | Mass Spectrometry | Neoadjuvant Therapy - methods | Biomarkers, Tumor - metabolism | Chromatography, Liquid | Prostatectomy | Aged | Prostate-Specific Antigen - metabolism | Deoxyguanosine - analogs & derivatives | Prostatic Neoplasms - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text 174 A PHASE II RANDOMIZED CONTROLLED TRIAL OF POMX VS. PLACEBO PRIOR TO RADICAL PROSTATECTOMY
by Freedland, Stephen and Carducci, Michael and Kroeger, Nils and Partin, Alan and Rao, Jian-yu and Jin, Yusheng and Kerkoutian, Susan and Wu, Hong and Li, YunFeng and Creel, Patricia and Mundy, Kelly and Gurganus, Robin and Fedor, Helen and King, Serina and Heber, David and Zhang, Yanjun and Pantuck, Allan
The Journal of urology, ISSN 0022-5347, 2012, Volume 187, Issue 4, pp. e73 - e73
Urology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text MP53-01 PERFORMANCE OF MULTI-PARAMETRIC MRI FOR HIGH GRADE PROSTATE CANCER: CORRELATION WITH WHOLE-MOUNT PATHOLOGY
by Le, Jesse and Tan, Nelly and Kerkoutian, Susan and Margolis, Daniel and Lu, David and Kwan, Lorna and Raman, Steven and Reiter, Robert
The Journal of urology, ISSN 0022-5347, 2014, Volume 191, Issue 4, pp. e588 - e588
Urology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A Double Blind, Randomized, Neoadjuvant Study of the Tissue effects of POMx Pills in Men with Prostate Cancer Prior to Radical Prostatectomy
by Freedland, Stephen J and Carducci, Michael and Kroeger, Nils and Partin, Alan and Rao, Jian-yu and Jin, Yusheng and Kerkoutian, Susan and Wu, Hong and Li, Yunfeng and Creel, Patricia and Mundy, Kelly and Gurganus, Robin and Fedor, Helen and King, Serina A and Zhang, Yanjun and Heber, David and Pantuck, Allan J
Cancer prevention research (Philadelphia, Pa.), ISSN 1940-6207, 10/2013, Volume 6, Issue 10, pp. 1120 - 1127
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.